Enabled by our proprietary switch-control kinase inhibitor platform, we have built a diverse pipeline of wholly-owned, orally administered drug candidates that includes 3 clinical-stage and 2 research-stage programs.
Latest News & Events
“There have been a lot of ups and downs of my journey and sometimes I get a little frightened but through it all I’ve tried to stay positive. To be honest, it’s difficult sometimes but I feel the longer I fight, the more opportunity there is for future medical solutions. My goal is to hang around long enough so that when researchers are successful, I’m successful. Hope is, and always will be, the magic ingredient… Keep hope alive.” Watch his story
MAKING A DIFFERENCE
At Deciphera we place a premium on being innovative and creative in our approach and relentless in our efforts to help patients live longer and healthier lives. We strive to combine great science, focus, and collaboration and an exciting, fun and energizing work environment.